Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Suhartono

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Vox Sanguinis|October 28, 1998
Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLASL Biesert, H Suhartono
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Virus validation experiments on the production process of OCTAVI SDPlusL Biesert, S Lemon, H Suhartono, et al.
Journal of Medical Virology|April 1, 1996
Viral safety of a new highly purified factor VIII (OCTATE)L Biesert, S Lemon, A Goudeau, et al.
Archiv Der Pharmazie|March 1, 1995
[Pyrido(3,2-e)(1,4)diazepines--synthesis and testing of anti-HIV-1 activity]K Görlitzer, C Wilpert, H Rübsamen-Waigmann, et al.
Behring Institute Mitteilungen|July 1, 1991
Biochemical and genetical analysis of AZT-resistant HIV-mutantsL Biesert, F Zimmermann, B Schröder, et al.
AIDS (London, England)|December 1, 1988
Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compoundL Biesert, H Suhartono, I Winkler, et al.
Medical Microbiology and Immunology|January 1, 1990
Anti-human immunodeficiency virus (HIV) drug HOE/BAY946 increases membrane hydrophobicity of human lymphocytes and specifically suppresses HIV-protein synthesisL Biesert, M Adamski, G Zimmer, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 1995
Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptidesS Horvat, L Varga-Defterdarović, J Horvat, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 28, 2006
Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate)M Stadler, G Gruber, C Kannicht, et al.
Infection|January 1, 1991
Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4+ cell counts, and HIV antigenH Rübsamen-Waigmann, B Schröder, L Biesert, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Vox Sanguinis|October 28, 1998
Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLASL Biesert, H Suhartono
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Virus validation experiments on the production process of OCTAVI SDPlusL Biesert, S Lemon, H Suhartono, et al.
Journal of Medical Virology|April 1, 1996
Viral safety of a new highly purified factor VIII (OCTATE)L Biesert, S Lemon, A Goudeau, et al.
Archiv Der Pharmazie|March 1, 1995
[Pyrido(3,2-e)(1,4)diazepines--synthesis and testing of anti-HIV-1 activity]K Görlitzer, C Wilpert, H Rübsamen-Waigmann, et al.
Behring Institute Mitteilungen|July 1, 1991
Biochemical and genetical analysis of AZT-resistant HIV-mutantsL Biesert, F Zimmermann, B Schröder, et al.
AIDS (London, England)|December 1, 1988
Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compoundL Biesert, H Suhartono, I Winkler, et al.
Medical Microbiology and Immunology|January 1, 1990
Anti-human immunodeficiency virus (HIV) drug HOE/BAY946 increases membrane hydrophobicity of human lymphocytes and specifically suppresses HIV-protein synthesisL Biesert, M Adamski, G Zimmer, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 1, 1995
Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptidesS Horvat, L Varga-Defterdarović, J Horvat, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 28, 2006
Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate)M Stadler, G Gruber, C Kannicht, et al.
Infection|January 1, 1991
Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4+ cell counts, and HIV antigenH Rübsamen-Waigmann, B Schröder, L Biesert, et al.
Pageof 1